HIGHLIGHTS
- who: Scintigraphy A et al. from the Mallinckrodt InstituteWashington University have published the research: Adverse Clinical Events at the Injection Site Are Exceedingly Rare After Reported Radiopharmaceutical Extravasation in Patients Undergoing 99mTc-MDP Whole-Body Bone Scintigraphy: A 12-Year Experience, in the Journal: (JOURNAL)
- what: The aim of this study was to determine whether 99mTc-MDP RPE in patients undergoing WBBS is associated with adverse clinical events, in the short term or the long term. Two case reports included in the review describe ulcer development in 2 patients (after 2 and 3 y) after . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.